Current and historical daily PE Ratio for Sorrento Therapeutics Inc (
) from 2013 to May 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sorrento Therapeutics stock (FRA:8STN) PE ratio as of May 23 2024 is 0.
More Details
Sorrento Therapeutics Inc (FRA:8STN) PE Ratio (TTM) Chart
Sorrento Therapeutics Inc (FRA:8STN) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 941
- 1
- 2
- 3
- 4
- 5
- 6
- 11
Sorrento Therapeutics PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-05-23 | At Loss | 2022-12-29 | At Loss |
2023-03-03 | At Loss | 2022-12-28 | At Loss |
2023-03-02 | At Loss | 2022-12-27 | At Loss |
2023-03-01 | At Loss | 2022-12-23 | At Loss |
2023-02-27 | At Loss | 2022-12-22 | At Loss |
2023-02-24 | At Loss | 2022-12-21 | At Loss |
2023-02-23 | At Loss | 2022-12-20 | At Loss |
2023-02-22 | At Loss | 2022-12-19 | At Loss |
2023-02-21 | At Loss | 2022-12-16 | At Loss |
2023-02-20 | At Loss | 2022-12-15 | At Loss |
2023-02-17 | At Loss | 2022-12-14 | At Loss |
2023-02-16 | At Loss | 2022-12-13 | At Loss |
2023-02-15 | At Loss | 2022-12-12 | At Loss |
2023-02-14 | At Loss | 2022-12-09 | At Loss |
2023-02-13 | At Loss | 2022-12-08 | At Loss |
2023-02-10 | At Loss | 2022-12-07 | At Loss |
2023-02-09 | At Loss | 2022-12-06 | At Loss |
2023-02-08 | At Loss | 2022-12-05 | At Loss |
2023-02-07 | At Loss | 2022-12-02 | At Loss |
2023-02-06 | At Loss | 2022-12-01 | At Loss |
2023-02-03 | At Loss | 2022-11-30 | At Loss |
2023-02-02 | At Loss | 2022-11-29 | At Loss |
2023-02-01 | At Loss | 2022-11-28 | At Loss |
2023-01-30 | At Loss | 2022-11-25 | At Loss |
2023-01-27 | At Loss | 2022-11-24 | At Loss |
2023-01-26 | At Loss | 2022-11-23 | At Loss |
2023-01-25 | At Loss | 2022-11-22 | At Loss |
2023-01-24 | At Loss | 2022-11-21 | At Loss |
2023-01-23 | At Loss | 2022-11-18 | At Loss |
2023-01-20 | At Loss | 2022-11-17 | At Loss |
2023-01-19 | At Loss | 2022-11-16 | At Loss |
2023-01-18 | At Loss | 2022-11-15 | At Loss |
2023-01-17 | At Loss | 2022-11-14 | At Loss |
2023-01-16 | At Loss | 2022-11-11 | At Loss |
2023-01-13 | At Loss | 2022-11-10 | At Loss |
2023-01-12 | At Loss | 2022-11-09 | At Loss |
2023-01-11 | At Loss | 2022-11-08 | At Loss |
2023-01-10 | At Loss | 2022-11-07 | At Loss |
2023-01-09 | At Loss | 2022-11-04 | At Loss |
2023-01-06 | At Loss | 2022-11-03 | At Loss |
2023-01-05 | At Loss | 2022-11-02 | At Loss |
2023-01-04 | At Loss | 2022-11-01 | At Loss |
2023-01-03 | At Loss | 2022-10-28 | At Loss |
2023-01-02 | At Loss | 2022-10-27 | At Loss |
2022-12-30 | At Loss | 2022-10-26 | At Loss |
Sorrento Therapeutics Inc (FRA:8STN) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Sorrento Therapeutics Inc
NAICS : 325414
SIC : 8731
ISIN : US83587F2020
Description